These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

725 related articles for article (PubMed ID: 31604111)

  • 1. Revisiting the intersection of amyloid, pathologically modified tau and iron in Alzheimer's disease from a ferroptosis perspective.
    Derry PJ; Hegde ML; Jackson GR; Kayed R; Tour JM; Tsai AL; Kent TA
    Prog Neurobiol; 2020 Jan; 184():101716. PubMed ID: 31604111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iron and Ferroptosis as Therapeutic Targets in Alzheimer's Disease.
    Gleason A; Bush AI
    Neurotherapeutics; 2021 Jan; 18(1):252-264. PubMed ID: 33111259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iron and Targeted Iron Therapy in Alzheimer's Disease.
    Wang J; Fu J; Zhao Y; Liu Q; Yan X; Su J
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implications of liquid-liquid phase separation and ferroptosis in Alzheimer's disease.
    Wang F; Chen Z; Zhou Q; Sun Q; Zheng N; Chen Z; Lin J; Li B; Li L
    Neuropharmacology; 2024 Nov; 259():110083. PubMed ID: 39043267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polycatechols inhibit ferroptosis and modulate tau liquid-liquid phase separation to mitigate Alzheimer's disease.
    Moorthy H; Ramesh M; Padhi D; Baruah P; Govindaraju T
    Mater Horiz; 2024 Jul; 11(13):3082-3089. PubMed ID: 38647314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mini-Review: Is iron-mediated cell death (ferroptosis) an identical factor contributing to the pathogenesis of some neurodegenerative diseases?
    Viktorinova A; Durfinova M
    Neurosci Lett; 2021 Feb; 745():135627. PubMed ID: 33440237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LINC00472 Regulates Ferroptosis of Neurons in Alzheimer's Disease via FOXO1.
    Lin P; Wang J; Li Y; Li G; Wang Y
    Dement Geriatr Cogn Disord; 2024; 53(3):107-118. PubMed ID: 38574473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ferroptosis: A new strategy for targeting Alzheimer's disease.
    Qiang RR; Xiang Y; Zhang L; Bai XY; Zhang D; Li YJ; Yang YL; Liu XL
    Neurochem Int; 2024 Sep; 178():105773. PubMed ID: 38789042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ferroptosis as a mechanism of neurodegeneration in Alzheimer's disease.
    Jakaria M; Belaidi AA; Bush AI; Ayton S
    J Neurochem; 2021 Dec; 159(5):804-825. PubMed ID: 34553778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eriodictyol ameliorates cognitive dysfunction in APP/PS1 mice by inhibiting ferroptosis via vitamin D receptor-mediated Nrf2 activation.
    Li L; Li WJ; Zheng XR; Liu QL; Du Q; Lai YJ; Liu SQ
    Mol Med; 2022 Jan; 28(1):11. PubMed ID: 35093024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ferroptosis: a potential therapeutic target for Alzheimer's disease.
    Yang L; Nao J
    Rev Neurosci; 2023 Jul; 34(5):573-598. PubMed ID: 36514247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Striking while the iron is hot: Iron metabolism and ferroptosis in neurodegeneration.
    Masaldan S; Bush AI; Devos D; Rolland AS; Moreau C
    Free Radic Biol Med; 2019 Mar; 133():221-233. PubMed ID: 30266679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Revisiting the intersection of microglial activation and neuroinflammation in Alzheimer's disease from the perspective of ferroptosis.
    Wang M; Tang G; Zhou C; Guo H; Hu Z; Hu Q; Li G
    Chem Biol Interact; 2023 Apr; 375():110387. PubMed ID: 36758888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tetrahydroxy stilbene glycoside ameliorates Alzheimer's disease in APP/PS1 mice via glutathione peroxidase related ferroptosis.
    Gao Y; Li J; Wu Q; Wang S; Yang S; Li X; Chen N; Li L; Zhang L
    Int Immunopharmacol; 2021 Oct; 99():108002. PubMed ID: 34333354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metal Ions in Alzheimer's Disease: A Key Role or Not?
    Liu Y; Nguyen M; Robert A; Meunier B
    Acc Chem Res; 2019 Jul; 52(7):2026-2035. PubMed ID: 31274278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Energy Crisis Links to Autophagy and Ferroptosis in Alzheimer's Disease: Current Evidence and Future Avenues.
    He DL; Fan YG; Wang ZY
    Curr Neuropharmacol; 2023; 21(1):67-86. PubMed ID: 35980072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Mechanisms and Genetics of Oxidative Stress in Alzheimer's Disease.
    Cioffi F; Adam RHI; Broersen K
    J Alzheimers Dis; 2019; 72(4):981-1017. PubMed ID: 31744008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of ferroptosis in Alzheimer's disease and therapeutic effects of natural plant products: A review.
    Zhao D; Yang K; Guo H; Zeng J; Wang S; Xu H; Ge A; Zeng L; Chen S; Ge J
    Biomed Pharmacother; 2023 Aug; 164():114312. PubMed ID: 37210894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening of treatment targets for Alzheimer's disease from the molecular mechanisms of impairment by β-amyloid aggregation and tau hyperphosphorylation.
    Lin LF; Luo HM
    Neurosci Bull; 2011 Feb; 27(1):53-60. PubMed ID: 21270904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidative stress and redox-active iron in Alzheimer's disease.
    Honda K; Casadesus G; Petersen RB; Perry G; Smith MA
    Ann N Y Acad Sci; 2004 Mar; 1012():179-82. PubMed ID: 15105265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.